MLV p30 Antikörper
-
- Target
- MLV p30
- Reaktivität
- Moloney Murine Leukemia Virus (MoMuLV)
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Unkonjugiert
- Applikation
- ELISA, Western Blotting (WB)
- Spezifität
- MLV Gag, p30
- Aufreinigung
- Protein G affinity purified
- Immunogen
- Full length recombinant MLV-Gag p30 capside protein,purified from E. coli
- Klon
- 4B2
- Isotyp
- IgG
-
-
- Applikationshinweise
- ELISA1:16 000, WB 1:1500. Monoclonal antibody working titer has to be established practically for each particular antigen and assay format
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/ml
- Buffer
- PBS pH 7.4, 0.1%
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Divide antibody into aliquots prior usage. Avoid multiple freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- This product is shipped in non-frozen liquid form in ambient conditions
-
- Target
- MLV p30
- Substanzklasse
- Viral Protein
- Hintergrund
- Murine leukemia viruses belong to family ofRetroviruses group and are named for their ability to cause cancer in mice.Some form of MLV’s are used in cancer research. The retroviral Gag protein plays importantroles at several stages in the viral life cycle. Late in infection, the Gagprecursor protein acts to mediate the assembly and release of virion particles.Afterbudding, the core matures by cleavage of Gag precursor protein intothe mature core proteins, the matrix (MA), capsid (CA) andnucleocapsid proteins. These separated Gag proteins then play roles in the early stages ofinfection
-